학술논문
Impact of Insertions in the HIV-1 P6 Ptapp Region on the Virological Response to Amprenavir
Document Type
Article
Author
Lastere, Stephane; Dalban, Cecile; Collin, Gilles; Descamps, Diane; Girard, Pierre-Marie; Clavel, Francois; Costagliola, Dominique; Brun-Vezinet, Francoise; Brun-Vezinet, F; Clavel, F; Costagliola, D; Dalban, C; Girard, PM; Matheron, S; Meynard, JL; Morand-Joubert, L; Peytavin, G; Vray, M; Beguinot, I; Waldner, A; Beumont, M; Semaille, C; Bentata, M; Berlureau, P; Gérard, L; Molina, JM; Hor, R; Bayol-Honnet, G; Lascoux-Combe, C; Drobacheff, C; Hoen, B; Dupon, M; Lacut, JY; Goujard, C; Rousseau, C; Vincent, V; Diemer, M; Lepeu, G; Zerazhi, H; de Truchis, P; Berthé, H; Jeantils, V; Tazi, C Taleb; Vittecoq, D; Escaut, L; Dupont, B; Nait-Ighil, L; Rozenbaum, W; Nguyen, T Huyen; Boué, F; Galanaud, P; Kazatchkine, M; Piketty, C; Bernasconi, C; Salmon-Ceron, D; Michon, C; Chandemerle, C; Lascaux, AS; Magnier, JD; Schneider, L; Ait-Mohand, H; Simon, A; Herson, S; Bollens, D; Picard, O; Tangre, P; Bonarek, M; Morlat, P; Trépo, C; Cotte, L; Gastaut, JA; Poizot-Martin, I; Moran, G; Masson, S; Bennai, Y; Belarbi, L; Prevot, MH; Fournier, I; Reynes, J; Baillat, V; Raffi, F; Esnault, JL; Ceppi, C; Cassuto, JP; Arvieux, C; Chapplain, JM; Rey, D; Krantz, V; Besnier, JM; Bastides, F; Obadia, M; Aquilina, C; Bazin, C; Verdon, R; Piroth, L; Grappin, M; Sissoko, D; Valette, M; May, T; Burty, C; Debab, Y; Caron, F; Elharrar, B; Launay, O; Winter, C; Chapuis, L; Auperin, I; Gilquin, J
Source
Antiviral Therapy; February 2004, Vol. 9 Issue: 2 p221-227, 7p
Subject
Language
ISSN
13596535
Abstract
We evaluated the impact of genetic changes within p6Gaggene on the virological response (VR, mean decrease in plasma viral load at week 12) to unboosted amprenavir (APV). Gag-protease fragments, including gag p2, p7, p1, p6 regions and whole protease (PR) were sequenced from baseline plasma specimens of 84 highly pre-treated but APV-naive patients included in the NARVAL (ANRS 088) trial. The correlation between baseline p6Gagpolymorphism, PR mutations, baseline characteristics and VR to APV was analysed in univariate analysis. Insertions (P459Ins) within p6 protein, leading to partial or complete duplication of the PTAPP motif, were significantly associated with a decreased VR (P459Ins versus wild-type; –0.3 ±0.8 vs –1.1 ±1.2 log copies/ml, P=0.007) and were more frequent when the V82A/F/T/S PR mutation was present (P=0.020). In multivariate analysis, after adjustment on the predictive factors of the VR in the NARVAL trial and on the PR mutations linked with response, there was a strong trend to an association (P=0.058) between the presence of P459Ins and an altered VR. In conclusion, these results suggest that insertions in the p6 region of HIV-1 gag gene may affect the VR, in highly pre-treated patients receiving an unboosted APV-containing regimen.